# Application of VA-ECMO combined with IABP in a patient with cardiac arrest following fulminant myocarditis

**Authors:** Yixin He, Ying Yang

PMC · DOI: 10.1186/s13019-026-03851-1 · 2026-02-04

## TL;DR

This paper describes a case where VA-ECMO and IABP helped save a patient with severe heart inflammation.

## Contribution

The case highlights the successful use of combined mechanical circulatory support in treating fulminant myocarditis.

## Key findings

- A 36-year-old patient with fulminant myocarditis was successfully treated with VA-ECMO and IABP.
- Timely mechanical circulatory support improved survival in a critical cardiac arrest case.
- Early recognition and intervention are key to managing fulminant myocarditis.

## Abstract

Fulminant myocarditis is a severe cardiac condition characterized by rapid progression and high mortality. In recent years, advancements in medical technology, particularly the application of mechanical circulatory support, have significantly improved patient outcomes.

A 36-year-old male patient was admitted with a history of “fever for 5 days and chest tightness and pain for 2 days”.He was diagnosed with acute myocarditis and subsequently experienced cardiac arrest. After resuscitation, he was transferred to the medical ICU, where he received VA-ECMO and IABP support therapy, eventually recovering and being discharged.

Early recognition, timely intervention, and mechanical circulatory support are crucial in the treatment of fulminant myocarditis, significantly enhancing patient survival rates.

## Linked entities

- **Diseases:** cardiac arrest (MONDO:0000745)

## Full-text entities

- **Diseases:** cardiac arrest (MESH:D006323), myocarditis (MESH:D009205)
- **Chemicals:** VA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964875/full.md

---
Source: https://tomesphere.com/paper/PMC12964875